Abooshahab, R. et al. 2025. Targeting metabolic vulnerabilities in breast cancer cells by combining PEDF and doxorubicin: pathway insights from GC/MS-based metabolomics. EXCLI Journal. 24, (Aug. 2025), 1037–1055. DOI:https://doi.org/10.17179/excli2025-8508.